Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析

◆英語タイトル:Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0986
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥51,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Advanced Proteome Therapeutics Corp (APC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Advanced Proteome Therapeutics Corporation (APC) is a biopharmaceutical company that focuses on the development of anticancer therapeutics that capitalizes on the properties of a natural human protein. It creates, develops and commercializes novel therapies. The company is advancing a site-specific protein modification technology platform for the development of proprietary human protein pharmaceuticals with enhanced therapeutic properties and greater affinity for the target cancer cells and tumors. The patent pending technology combines anti-cancer therapies in a single agent to directly target cancerous tumors and avoid destroying normal cells. The company carries out its operations through its subsidiary; Advanced Proteome Therapeutics Inc. APC is headquartered in Boston, Massachusetts, the US.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Advanced Proteome Therapeutics Corp – Key Facts
Advanced Proteome Therapeutics Corp – Key Employees
Advanced Proteome Therapeutics Corp – Key Employee Biographies
Advanced Proteome Therapeutics Corp – Major Products and Services
Advanced Proteome Therapeutics Corp – History
Advanced Proteome Therapeutics Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Advanced Proteome Therapeutics Corp – Business Description
Advanced Proteome Therapeutics Corp – SWOT Analysis
SWOT Analysis – Overview
Advanced Proteome Therapeutics Corp – Strengths
Advanced Proteome Therapeutics Corp – Weaknesses
Advanced Proteome Therapeutics Corp – Opportunities
Advanced Proteome Therapeutics Corp – Threats
Advanced Proteome Therapeutics Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Advanced Proteome Therapeutics Corp, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Advanced Proteome Therapeutics Corp, Key Facts
Advanced Proteome Therapeutics Corp, Key Employees
Advanced Proteome Therapeutics Corp, Key Employee Biographies
Advanced Proteome Therapeutics Corp, Major Products and Services
Advanced Proteome Therapeutics Corp, History
Advanced Proteome Therapeutics Corp, Other Locations
Advanced Proteome Therapeutics Corp, Subsidiaries
Advanced Proteome Therapeutics Corp, Key Competitors
Advanced Proteome Therapeutics Corp, Ratios based on current share price
Advanced Proteome Therapeutics Corp, Annual Ratios
Advanced Proteome Therapeutics Corp, Interim Ratios
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Advanced Proteome Therapeutics Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Advanced Proteome Therapeutics Corp, Performance Chart (2015 - 2019)
Advanced Proteome Therapeutics Corp, Ratio Charts
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Advanced Proteome Therapeutics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Societe Des Bains De Mer Sa
    Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report Summary Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Freshfields Bruckhaus Deringer LLP:企業の戦略・SWOT・財務情報
    Freshfields Bruckhaus Deringer LLP - Strategy, SWOT and Corporate Finance Report Summary Freshfields Bruckhaus Deringer LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Venus Remedies Ltd (VENUSREM)-製薬・医療分野:企業M&A・提携分析
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company manufactures complex formulations for oncology injections, neurology, antiseptic, pain management, anti infectives, oncology lyophilized, l …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Perusahaan Gas Negara (Persero) Tbk (PGN) is a downstream energy that transmits and distributes natural gas. The company plans, constructs and develops downstream natural gas businesses and carries out processing, transportation, storage and trading of natural gas. It produces, trades and …
  • Mirvac Group:企業の戦略・SWOT・財務情報
    Mirvac Group - Strategy, SWOT and Corporate Finance Report Summary Mirvac Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • State Bank Of India
    State Bank Of India - Strategy, SWOT and Corporate Finance Report Summary State Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析
    Summary Ampio Pharmaceuticals Inc (Ampio) formerly Chay Enterprises Inc, operates as a bio pharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory co …
  • Romaero SA Bucuresti:企業の戦略・SWOT・財務情報
    Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report Summary Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Epinex Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a medical device company that develops rapid diagnostic tests. The company’s products include over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device, among …
  • Hafslund AS:企業の戦略・SWOT・財務情報
    Hafslund AS - Strategy, SWOT and Corporate Finance Report Summary Hafslund AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Wuhan Kaidi Electric Power Co Ltd (000939):電力:M&Aディール及び事業提携情報
    Summary Wuhan Kaidi Electric Power Co Ltd (Wuhan Kaidi) is a renewable energy company that offers power supply and new energies technology and services. The company produces biomass energy from forestry and agricultural residues. Its services include technical research and development, investment an …
  • Prothena Corp Plc (PRTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Prothena Corp Plc (Prothena) is a clinical biotechnology company, which discovers, develops and markets novel medicines that are indicated for the treatment of diseases associated with neuroscience and orphan diseases. The company develops monoclonal antibodies directed specifically at disea …
  • Parkland Fuel Corporation (PKI):石油・ガス:M&Aディール及び事業提携情報
    Summary Parkland Fuel Corp (Parkland) is a downstream energy company. It markets various fuel and petroleum products, including gasoline, propane, lubricants, diesel, heating oil, and other petroleum products. The company maintains a portfolio of supply relationships, storage infrastructure, and thi …
  • Insmed Inc (INSM)-医療機器分野:企業M&A・提携分析
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline includes …
  • The Bank of East Asia, Limited:企業の戦略・SWOT・財務情報
    The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Terme Dobrna D.D.:企業の戦略・SWOT・財務分析
    Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Dongfang Electric Corporation Ltd (1072):電力:M&Aディール及び事業提携情報
    Summary Dongfang Electric Corporation Ltd (DEC), a subsidiary of Dongfang Electric Corporation, is a power equipment and services company. It designs, manufactures and sells power generation equipment, including turbines for hydro, thermal, and nuclear power generation, wind turbine generator sets, …
  • EXOR SpA:企業のM&A・事業提携・投資動向
    EXOR SpA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EXOR SpA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • RCI Banque SA:企業の戦略的SWOT分析
    RCI Banque SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆